T. Rowe Price Associates’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $602K | Buy |
9,222
+1,133
| +14% | +$74K | ﹤0.01% | 2216 |
|
|
2025
Q1 | $542K | Buy |
8,089
+801
| +11% | +$53.7K | ﹤0.01% | 2218 |
|
|
2024
Q4 | $403K | Buy |
7,288
+1,220
| +20% | +$67.5K | ﹤0.01% | 2364 |
|
|
2024
Q3 | $363K | Buy |
6,068
+186
| +3% | +$11.1K | ﹤0.01% | 2388 |
|
|
2024
Q2 | $375K | Buy |
5,882
+1,713
| +41% | +$109K | ﹤0.01% | 2308 |
|
|
2024
Q1 | $289K | Buy |
+4,169
| New | +$289K | ﹤0.01% | 2448 |
|